Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis

被引：65
作者：
Furue, Kazuhisa [1 ]
Ito, Takamichi [1 ]
Furue, Masutaka [1 ,2 ,3 ]
机构：
[1] Kyushu Univ, Dept Dermatol, Higashi Ku, Maidashi 3-1-1, Fukuoka, Fukuoka 8128582, Japan
[2] Kyushu Univ, Dept Dermatol, Div Skin Surface Sensing, Higashi Ku, Maidashi 3-1-1, Fukuoka, Fukuoka 8128582, Japan
[3] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin, Higashi Ku, Maidashi 3-1-1, Fukuoka, Fukuoka 8128582, Japan
来源：
CYTOKINE | 2018年 / 111卷
关键词：
Psoriasis; Psoriatic arthritis; Biologics; efficacy; TNF-alpha/IL-23/IL-17; axis; SEVERE PLAQUE PSORIASIS; QUALITY-OF-LIFE; GENERALIZED PUSTULAR PSORIASIS; BODY-MASS INDEX; JAPANESE PATIENTS; DOUBLE-BLIND; CLINICAL-PRACTICE; SEVERITY INDEX; MONOCLONAL-ANTIBODY; INFLIXIMAB THERAPY;
D O I：
10.1016/j.cyto.2018.08.025
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Psoriasis and psoriatic arthritis cause significant physical and psychological burdens for afflicted individuals. An accelerated TNF-alpha/IL-23/IL-17 axis is their major pathomechanism; therefore, anti-TNF-alpha/IL-23/IL-17 biologics are very effective for the treatment of skin and joint lesions in psoriasis and psoriatic arthritis. Given that the IL-17 signature is more upregulated in the skin than in synovium in psoriatic arthritis, anti-IL-23/IL-17 agents seem to be superior to anti-TNF-alpha remedies in the treatment of skin lesions. In this review, we focus on the differential efficacy of anti-TNF-alpha/IL-23/IL-17 biologics in psoriasis and psoriatic arthritis.
引用
收藏
页码：182 / 188
页数：7
相关论文
共 149 条
  • [1] Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial
    Abe, Masatoshi
    Nishigori, Chikako
    Torii, Hideshi
    Ihn, Hironobu
    Ito, Kei
    Nagaoka, Makoto
    Isogawa, Naoki
    Kawaguchi, Isao
    Tomochika, Yukiko
    Kobayashi, Mihoko
    Tallman, Anna M.
    Papp, Kim A.
    [J]. JOURNAL OF DERMATOLOGY, 2017, 44 (11) : 1228 - 1237
  • [2] Case of generalized pustular psoriasis exacerbated during pregnancy, successfully treated with infliximab
    Adachi, Akimasa
    Komine, Mayumi
    Hirano, Tomoko
    Tsuda, Hidetoshi
    Karakawa, Masaru
    Murata, Satoru
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (12) : 1439 - 1440
  • [3] Association of psoriasis with Hashimoto's thyroiditis, Sjogren's syndrome and dermatomyositis
    Akiyama, Michiko
    Ueno, Takashi
    Kanzaki, Akiko
    Kuwana, Masataka
    Nagao, Mototsugu
    Saeki, Hidehisa
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (06) : 711 - 712
  • [4] Internalized stigma in psoriasis: A multicenter study
    Alpsoy, Erkan
    Polat, Mualla
    Fettahlioglu-Karaman, Bilge
    Karadag, Ayse Serap
    Kartal-Durmazlar, Pelin
    Yalcin, Basak
    Emre, Selma
    Didar-Balci, Didem
    Bilgic-Temel, Asli
    Arca, Ercan
    Koca, Rafet
    Gunduz, Kamer
    Borlu, Murat
    Ergun, Tulin
    Dogruk-Kacar, Seval
    Cordan-Yazici, Ayca
    Dursun, Pinar
    Bilgic, Ozlem
    Gunes-Bilgili, Serap
    Sendur, Neslihan
    Baysal, Ozge
    Halil-Yavuz, Ibrahim
    Yagcioglu, Gizem
    Yilmaz, Ertan
    Kavuzlu, Ufuk
    Senol, Yesim
    [J]. JOURNAL OF DERMATOLOGY, 2017, 44 (08) : 885 - 891
  • [5] Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics
    Asahina, Akihiko
    Kubo, Naoko
    Umezawa, Yoshinori
    Honda, Hiromi
    Yanaba, Koichi
    Nakagawa, Hidemi
    [J]. JOURNAL OF DERMATOLOGY, 2017, 44 (10) : 1112 - 1121
  • [6] Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study
    Asahina, Akihiko
    Torii, Hideshi
    Ohtsuki, Mamitaro
    Tokimoto, Toshimitsu
    Hase, Hidenori
    Tsuchiya, Tsuyoshi
    Shinmura, Yasuhiko
    Servin, Ofelia Reyes
    Nakagawa, Hidemi
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (11) : 1257 - 1266
  • [7] Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study
    Asahina, Akihiko
    Etoh, Takafumi
    Igarashi, Atsuyuki
    Imafuku, Shinichi
    Saeki, Hidehisa
    Shibasaki, Yoshiyuki
    Tomochika, Yukiko
    Toyoizumi, Shigeyuki
    Nagaoka, Makoto
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (08) : 869 - 880
  • [8] Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics
    Asahina, Akihiko
    Umezawa, Yoshinori
    Yanaba, Koichi
    Nakagawa, Hidemi
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (07) : 779 - 784
  • [9] TUR-PSO: A cross-sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey
    Atakan, Nilgun
    Yazici, Ayca Cordan
    Ozarmagan, Guzin
    Inaloz, Huseyin Serhat
    Gurer, Mehmet Ali
    Sabuncu, Ilham
    Kiremitci, Ummuhan
    Alper, Sibel
    Aytekin, Sema
    Arican, Ozer
    Polat, Mualla
    Dogan, Sibel
    Aldinc, Emre
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (03) : 298 - 304
  • [10] Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis
    Bae, Soo Hyeon
    Yun, Sook Jung
    Lee, Jee-Bum
    Kim, Seong-Jin
    Won, Young Ho
    Lee, Seung-Chul
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (06) : 643 - 649
12345678910